Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities by Rideout, Todd C et al.
© 2008 Rideout et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article 
which permits unrestricted noncommercial use, provided the original work is properly cited.
Vascular Health and Risk Management 2008:4(5) 1023–1033 1023
REVIEW
Guar gum and similar soluble ﬁ  bers 
in the regulation of cholesterol metabolism: 
Current understandings and future research 
priorities
Todd C Rideout1
Scott V Harding1
Peter JH Jones1
Ming Z Fan2
1Richardson Centre for Functional 
Foods and Nutraceuticals, University 
of Manitoba, Winnipeg, Manitoba, 
Canada; 2Centre for Nutrition 
Modeling, Department of Animal 
and Poultry Science, University 
of Guelph, Guelph, Ontario, Canada
Correspondence:   Todd C Rideout
Richardson Centre for Functional Foods 
and Nutraceuticals, University 
of Manitoba, 196 Innovation Drive
Winnipeg, MB R3T 6C5, Canada 
Tel +1 204 474 8383
Fax +1 204 474 7552
Email t_rideout@umanitoba.ca
Abstract: The hypocholesterolemic effects associated with soluble ﬁ  ber consumption are clear 
from animal model and human clinical investigations. Moreover, the modulation of whole-body 
cholesterol metabolism in response to dietary ﬁ  ber consumption, including intestinal cholesterol 
absorption and fecal sterol and bile acid loss, has been the subject of many published reports. 
However, our understanding of how dietary ﬁ  bers regulate molecular events at the gene/protein 
level and alter cellular cholesterol metabolism is limited. The modern emphasis on molecular 
nutrition and rapid progress in ‘high-dimensional’ biological techniques will permit further 
explorations of the role of genetic polymorphisms in determining the variable interindividual 
responses to soluble ﬁ  bers. Furthermore, with traditional molecular biology tools and the 
application of ‘omic’ technology, speciﬁ  c insight into how ﬁ  bers modulate the expression of 
genes and proteins that regulate intestinal cholesterol absorption and alter hepatic sterol balance 
will be gained. Detailed knowledge of the molecular mechanisms by which soluble ﬁ  bers reduce 
plasma cholesterol concentrations is paramount to developing novel ﬁ  ber-based “cocktails” that 
target speciﬁ  c metabolic pathways to gain maximal cholesterol reductions.
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Introduction
Dietary ﬁ  ber may be considered the ‘dinosaur’ of functional foods. The hypolipidemic 
effects and cardioprotective beneﬁ  ts associated with dietary soluble ﬁ  ber consumption 
are abundantly clear from the results of human clinical trials (Anderson et al 1984, 
1991, 2000b; Bell et al 1989; Braaten et al 1994; Naumann et al 2006), animal 
feeding studies (van Bennekum et al 2005; Venkatesan et al 2007), epidemiological 
investigations (Lairon et al 2005), and meta-analysis reports (Ripsin et al 1992; 
Anderson et al 2000a; Anderson and Major 2002; Castro et al 2005). Furthermore, the 
mechanisms by which soluble ﬁ  bers modulate cholesterol metabolism and effectively 
reduce circulating cholesterol concentrations have been the subject of many published 
reports (Fernandez et al 1999; Queenan et al 2007). Such an extensive research 
history begs the question: Is the ﬁ  ber story over? Advancements in any biological 
discipline often require an assessment of current knowledge and a reﬂ  ection on what 
is not understood or has yet to be pursued. The objective of this review is to assess 
what is known regarding the role of soluble dietary ﬁ  ber in modulating cholesterol 
metabolism and reducing cardiovascular disease risk. To contextualize the place of ﬁ  ber 
in modern human health and disease prevention, we will begin with a brief account of 
the history of dietary ﬁ  ber research and the modern dietary ﬁ  ber classiﬁ  cation system. 
An additional objective of this review article is to explore what is known regarding the Vascular Health and Risk Management 2008:4(5) 1024
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mechanisms by which ﬁ  ber consumption is thought to reduce 
plasma cholesterol concentrations. Finally, with the modern 
emphasis on molecular nutrition and the application of ‘high-
dimensional biology’ or ‘omic’ technology, we will review 
recent progress in understanding how ﬁ  ber consumption may 
regulate the enterohepatic metabolism of cholesterol at the 
molecular level and highlight current research priorities that 
will advance our existing knowledge base.
A brief history of dietary ﬁ  ber
In the mid 1970s, as the controversy surrounding the role of 
cholesterol in atherosclerosis reached an unparalleled point 
of contention within the medical community (Steinberg 
2004, 2005), the dietary ﬁ  ber hypothesis emerged as the 
new paradigm of nutrition in human health and disease 
prevention. While modern dietary ﬁ  ber nutrition stemmed 
from observational and epidemiological studies in the 1970s, 
the hypothesis that the consumption of coarse foods of plant 
origin could modulate human health was not an entirely new 
concept. As early as 430 BC, Hippocrates understood the 
link between dietary ﬁ  ber and the ‘diseases which befall a 
man’ and recognized that ‘to the human body it makes a great 
difference whether the bread be ﬁ  ne or coarse; of wheat with 
or without the hull’ (Adams 1939). Indeed, advances in the 
analysis (McCance et al 1936) and energy value (Atwater 
1900) of these ‘indigestible carbohydrates’ had already been 
made by the 1930s. However, during the ﬁ  rst half of the 20th 
century, published reports on the functionality of dietary ﬁ  ber 
were few and the idea that a group of indigestible plant car-
bohydrates could facilitate disease prevention did not receive 
much attention from the nutritional community.
In the 1970s, several researchers including Burkitt 
(1972), Trowell (1972a), Painter (1973), and Walker (1974) 
proposed that the low prevalence of cardiovascular diseases 
in developing countries was largely due to the consumption 
of a diet rich in ﬁ  ber. Following these initial observations, 
several early epidemiological investigations supported an 
inverse relationship between dietary ﬁ  ber consumption and 
the incidence of coronary heart disease (Morris et al 1977; 
Yano et al 1978; Kromhout et al 1982).
One of the earliest researchers to provide experimental 
evidence in support of a protective role of dietary ﬁ  ber against 
coronary heart disease was David Kritchevsky. Kritchevsky 
was intrigued that saturated fat feeding induced atheroscle-
rosis in rabbits fed semi-puriﬁ  ed diets, but not in chow-fed 
rabbits. Kritchevsky hypothesized that this discrepancy 
was likely due to the cardioprotective effects associated 
with dietary ﬁ  ber components in the commercial chow 
diets (Kritchevsky 1964). The results from Kritchevsky’s 
subsequent experiments supported his initial hypothesis of 
the cardioprotective effects of dietary ﬁ  bers (Kritchevsky 
and Tepper 1965, 1968).
Although the dietary ﬁ  ber hypothesis gained acceptance, a 
comprehensive deﬁ  nition of dietary ﬁ  ber was needed in order 
to effectively study the epidemiological, physiological, and 
analytical aspects of these indigestible dietary components. 
However, the development of a comprehensive deﬁ  nition 
of dietary ﬁ  ber that satisﬁ  ed the distinct considerations of 
nutritionists, food technologists, and food chemists became 
the subject of great debate. In 1972, Trowell originally 
deﬁ  ned dietary ﬁ  ber as ‘the skeletal remains of plant cells 
that are resistant to hydrolysis of the enzymes of man’ 
(Trowell 1972b). This deﬁ  nition was restricted to plant cell 
wall components including cellulose, hemicellulose, lignin, 
and other minor components such as waxes and cutin. This 
deﬁ  nition was subsequently amended to include plant storage 
polysaccharides such as gums and pectins, that have similar 
biological effects of traditional cell wall components, but 
did not have their origin in structures other than the cell wall 
(Trowell 1976).
With advances in analytical technology and a better under-
standing of the physiological implications of dietary ﬁ  ber, the 
American Association of Cereal Chemists (2001) proposed the 
following comprehensive deﬁ  nition: ‘dietary ﬁ  ber is the edible 
parts of plants or analogous carbohydrates that are resistant 
to digestion and absorption in the human small intestine with 
complete or partial fermentation in the large intestine. Dietary 
ﬁ  ber includes polysaccharides, oligosaccharides, lignin, and 
associated plant substances. Dietary ﬁ  ber promotes beneﬁ  cial 
physiological effects including laxation, and/or blood choles-
terol attenuation, and/or blood glucose attenuation’. Ha and 
colleagues (2000) have criticized physiological-based ﬁ  ber 
deﬁ  nitions that stress large intestinal fermentation without 
including possible interactions of dietary ﬁ  ber with other 
dietary components in the upper gastrointestinal tract.
More recently, the Joint FAO/WHO Expert Consultation 
on Carbohydrates in Human Nutrition (Mann et al 2007) 
conceded that a re-evaluation of the ﬁ  ber deﬁ  nition was 
warranted and proposed that dietary ﬁ  ber should be deﬁ  ned 
as ‘intrinsic plant cell wall polysaccharides’.
Current understanding 
in ﬁ  ber nutrition
Classiﬁ  cation of dietary ﬁ  ber
With years of research supporting the hypolipidemic 
effects and cardioprotective benefits associated with Vascular Health and Risk Management 2008:4(5) 1025
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ﬁ  ber consumption, recommendations for increased ﬁ  ber 
consumption from health authorities around the world are 
justiﬁ  ed (Heart and Stroke Foundation of Canada 2003; 
Lichtenstein et al 2006). However, it is also clear that actual 
ﬁ  ber consumption in North America is much lower than 
what is currently recommended (James et al 2003). This 
discrepancy may be due to the confusion created by the broad 
range of substances that are classiﬁ  ed under the umbrella 
of ‘dietary ﬁ  ber’ and the lack of knowledge concerning 
the effect of different ﬁ  bers on human health (Shamliyan 
et al 2006). Dietary ﬁ  bers are typically classiﬁ  ed according 
to various physical-chemical and physiological criteria 
including solubility, viscosity, and fermentability (James 
et al 2003). Generally, soluble ﬁ  bers such as guar gum 
(GG), pectin, and psyllium are highly viscous and are readily 
fermented to short-chain fatty acids (SCFA) in the large 
bowel in comparison with insoluble ﬁ  bers such as cellulose 
(James et al 2003). Furthermore, soluble ﬁ  bers elicit a much 
more pronounced hypolipidemic and hypoglycemic response 
than their insoluble counterparts (Fernandez 2001).
The variable hypocholesterolemic 
response to soluble ﬁ  ber consumption
Consumption of water-soluble, viscous-forming ﬁ  bers such 
as GG, pectin, and psyllium has consistently been shown 
to reduce plasma cholesterol in human subjects (Brown 
et al 1999; Knopp et al 1999; Schneeman 1999; Butt et al 
2007). The extent of cholesterol lowering in response to 
ﬁ  ber consumption is variable, depending on a number of 
factors including the nature of the background diet, type of 
dietary ﬁ  ber, length of adaptation period, and amount of ﬁ  ber 
consumed. Furthermore, much of this variability in the plasma 
lipid-changes reported in response to dietary ﬁ  ber consumption 
is thought to have a genetic basis (Cara et al 1992).
The greatest hypolipidemic effects in response to soluble 
ﬁ  ber consumption are seen in animal model investigations 
where experimental conditions allow ﬁ  ber intake to be 
above what is typically observed in humans. Fernandez 
and colleagues have reported a reduction in total plasma 
cholesterol up to 43% in guinea pigs fed a high cholesterol 
(0.25%) diet supplemented with 12.5% GG (Shen et al 
1998). Interestingly, the cholesterol-lowering effect of GG 
is more pronounced when consumed with a high-cholesterol 
diet compared with a cholesterol-free diet. In rats fed 7.5% 
GG, Moundras and colleagues (1997) reported total plasma 
cholesterol reductions of 14 and 32% with cholesterol-
free or cholesterol-enriched (0.3%) diets, respectively. 
Similarly, guinea pigs fed diets supplemented with 12.5% GG 
responded with a 22% reduction in plasma total cholesterol 
on a low-cholesterol (0.04%) diet, but demonstrated a 38% 
reduction in total plasma cholesterol on a high-cholesterol 
diet (0.25%) (Fernandez 1995).
Clinical investigations typically report low-density 
lipoprotein (LDL)-cholesterol reductions in the range 
of  6%–15% (Fernandez 2001). Following the consumption 
of 14 g/d of psyllium in twenty type 2 diabetic patients for 
6 weeks, Sierra and colleagues (2002) observed a reduction 
in total and LDL-cholesterol by 7% and 9%, respectively. 
In addition, a large reduction (25%) in LDL-cholesterol was 
observed in 24 healthy volunteers receiving 9 g of GG per day 
for 4 weeks (Khan et al 1981). Alternatively, a meta analysis 
of 67 controlled studies by Brown and colleagues (1999) 
suggested that consumption of 2–10 g of major dietary ﬁ  bers 
such as pectin, oat bran, guar gum and psyllium resulted in 
small but signiﬁ  cant reductions in total and LDL-cholesterol. 
Finally, postprandial circulating lipid concentrations have 
also been shown to shift favorably following the consumption 
of dietary ﬁ  ber. Consumption of a high ﬁ  ber test meal with 
15.7 g of   beta-glucan reduced postprandial cholesterol 
concentrations below the fasting level in 11 healthy men in 
comparison to a low ﬁ  ber test meal with 5.0 g of beta-glucan 
(Bourdon et al 1999).
Cholesterol-lowering mechanisms
of soluble ﬁ  bers
Our traditional understanding of how dietary soluble ﬁ  bers 
alter cholesterol metabolism and reduce circulating cholesterol 
concentrations is illustrated in Figure 1. It is widely accepted 
that soluble ﬁ  bers act primarily in the intestine to promote 
secondary responses in the liver and peripheral circulation 
from direct effects within the intestinal lumen (Fernandez 
et al 1997; Schneeman 1999). One of the primary actions 
of soluble ﬁ  bers in the intestine is to reduce dietary fat and 
cholesterol uptake (Schneeman 1999). Reductions in apparent 
intestinal cholesterol absorption have been reported in both 
human subjects (Simons et al 1982) and animal models 
(Levrat-Verny et al 2000). Furthermore, in vitro cholesterol 
uptake into everted sacs of rat proximal small intestine from 
a solution of micelles was reduced by 40% when GG was 
included in the incubation medium (Gee et al 1983). It has 
been proposed that the viscosity associated with soluble 
ﬁ  bers interferes with key physiological events in the cho-
lesterol absorptive process. These interference mechanisms 
include direct binding of cholesterol within the intestinal 
lumen (Andersson 1992), interference with the diffusion 
of luminal cholesterol toward the epithelial cell surface Vascular Health and Risk Management 2008:4(5) 1026
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(Schneeman 1999), and/or antagonization of the cholesterol 
emulsiﬁ  cation process (Minekus et al 2005). While our 
knowledge concerning the molecular mechanisms respon-
sible for cholesterol balance within intestinal enterocytes has 
greatly advanced in recent years, the reduction in cholesterol 
absorption in response to soluble ﬁ  ber consumption is most 
often attributed to viscosity with very little emphasis on the 
potential regulation of proteins that mediate intestinal cho-
lesterol absorption (Dikeman and Fahey 2006).
The hypocholesterolemic effects of soluble ﬁ  bers are also 
believed to result from an interference with the enterohe-
patic circulation of bile acids (Fernandez 2001). Marlett and 
colleagues (1994) concluded that the consumption of oat bran 
in normolipidemic young men decreased serum cholesterol 
by altering the composition of the enterohepatic bile acid 
pool and increasing the fecal loss of total bile acids. These 
observations were further demonstrated in human clinical stud-
ies by Lia and colleagues (1995), Andersson and colleagues 
(2002), and Ellegård and Andersson (2007). The dietary 
supplementation of psyllium at a level of 10% is associated 
with a dose-dependent increase in fecal bile acid excretion 
in rats (Buhman et al 2000). Similarly, native amylo-maize 
resistant starch, a modiﬁ  ed starch with similar physiological 
effects to soluble ﬁ  bers, has been shown to increase the fecal 
excretion of primary bile acids in human subjects (van Munster 
et al 1994). Interestingly, while GG was traditionally thought 
to reduce intestinal bile acid uptake, a series of reports in the 
late 1990’s suggest that intestinal bile acid ﬂ  ux to the liver may 
actually be increased in response to GG consumption (Favier 
et al 1998; Moundras et al 1997; Moriceau et al 2000). There-
fore, the traditional mechanisms by which GG reduces plasma 
cholesterol concentrations may have to be re-evaluated.
The reduction in intestinal cholesterol absorption and 
bile acid uptake in response to soluble ﬁ  ber consumption 
are believed to alter hepatic cholesterol homeostasis by 
effectively reducing cholesterol concentrations in the liver by 
two related mechanisms. Firstly, a decrease in the delivery of 
dietary cholesterol to the liver through chylomicron remnants 
results in a direct reduction in the hepatic cholesterol pool 
(Fernandez 2001). The dietary supplementation of GG at 
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Figure 1 Potential mechanisms responsible for the hypocholesterolemic effects associated with the consumption of soluble ﬁ  bers. Copyright © 2007.  Adapted with permission 
from Rideout TC, Yuan Z, Bakovic M, et al. 2007. Guar gum consumption increases hepatic nuclear SREBP2 and LDL receptor expression in pigs fed an atherogenic diet. 
J Nutr, 137:568–72.
Abbreviations:   ABCG5/G8,   ATP-binding cassette transporter G5 and G8; C, cholesterol; CE, cholesteryl ester; CYP7A, cholesterol 7a-hydroxylase; GG, guar 
gum;  LDLr, low-density lipoprotein receptor;  NPC1L1, Niemann-Pick-C-1 like 1; SCFA, short-chain fatty acids; SREBP2, sterol regulatory element binding protein 2.Vascular Health and Risk Management 2008:4(5) 1027
Dietary ﬁ  ber and cholesterol homeostasis
12.5% has been shown to reduce hepatic free and esteriﬁ  ed 
cholesterol levels by 21% and 16%, respectively, in guinea 
pigs (Fernandez 1995). Secondly, an increase in the fecal 
loss of bile acids and a reduction in the enterohepatic bile 
acid pool size may stimulate the liver to produce more bile 
acids from cholesterol, thus reducing hepatic free cholesterol 
concentrations (van Bennekum et al 2005).
The increased hepatic demand for cholesterol from the 
ﬁ  ber-induced reduction in hepatic microsomal free choles-
terol pool can be met by increasing the uptake of lipoprotein 
cholesterol from the plasma, the release of free cholesterol 
from intracellular storage of cholesteryl ester and membrane 
cholesterol, or by increasing hepatic cholesterol synthesis 
(Fernandez 2001; Rideout et al 2007). Consumption of 
various types of soluble ﬁ  bers has been shown to increase the 
fractional catabolic rate of LDL (Vergara-Jimenez et al 1998) 
and hepatic LDLr expression (Fernandez 1995; Fukishima 
et al 2001; Han et al 2004).
A compensatory increase in the expression of hepatic 
HMG-CoA reductase, the rate–limiting enzyme in choles-
terol biosynthesis, is thought to account for the reduction in 
the hepatic free cholesterol pool following the consumption 
of GG (Favier et al 1998), manufactured soluble ﬁ  ber from 
wood chips (Chai et al 2003), psyllium (Buhman et al 2000), 
and pectin (Garcia-Diez et al 1996). It has been suggested 
that GG elicits a hypocholesterolemic effect even in the face 
of an increase in hepatic cholesterol synthesis, as the increase 
in HMG-CoAr activity is not sufﬁ  cient to compensate for 
fecal steroid loss in rats fed a diet supplemented with 7.5% 
GG (Moundras et al 1997).
The reduction in hepatic free cholesterol concentrations 
following soluble ﬁ  ber consumption is thought to lead to 
a modiﬁ  cation of hepatic lipoprotein metabolism. Soluble 
ﬁ  ber consumption has been associated with a reduction in 
hepatic apolipoprotein B secretion and the formation of 
large triglyceride-rich, cholesteryl-ester-depleted very LDL 
(VLDL) particles (Fernandez 2001). This change in the 
endogenous cholesterol pathway results in a VLDL particle 
that is less prone to IDL and LDL conversion via extrahepatic 
lipases and LDL particles with a high peak density (Roy et al 
2000; Fernandez 2001).
The production of SCFA by bacterial fermentation in the 
large intestine is thought to have multiple health beneﬁ  ts and 
may be involved in mediating the hypocholesterolemic effects 
of dietary ﬁ  ber (Chen et al 1984). Furthermore, dietary ﬁ  bers 
with unique physiochemical properties elicit differential 
SCFA proﬁ  les in the large intestine (Rideout et al 2008). 
Strong evidence for this SCFA-induced hypocholesterolemic 
effect from ﬁ  ber fermentation comes from the observation 
that the cholesterol-lowering action of beet pulp disap-
pears in rats following the removal of the cecum, both the 
cecum and colon, but not upon the removal of the colon 
alone (Nishimura et al 1993). However, the reduction in 
total cholesterol, LDL-cholesterol, and apolipoprotein B 
concentrations in ileostomy subjects fed an oat bran based 
high ﬁ  ber diet suggests that large intestinal ﬁ  ber fermentation 
is not necessary for cholesterol-reductions in human subjects 
(Zhang et al 1992). Particular emphasis has been placed on 
the role of butyrate as a signaling molecule that is important 
in regulating intestinal function and systemic cholesterol 
metabolism (Marcil et al 2002). Moreover, it has recently 
been suggested that butyrate may impair the assembly of 
triglyceride-rich lipoproteins within intestinal enterocytes, 
as a decrease in the basolateral efﬂ  ux of cholesteryl ester in 
response to butyrate has been demonstrated in Caco-2 cells 
(Marcil et al 2003).
Research priorities in dietary 
ﬁ  ber and cholesterol metabolism
Individual physiological responses
to dietary ﬁ  bers
The future of functional foods in modulating human health is 
closely connected to the concept of ‘personalized nutrition’ 
(Vakili and Caudill 2007). The ability to speciﬁ  cally tailor 
dietary treatment based on individual genetic polymorphisms 
will bolster the importance of the diet in disease prevention 
and potentially revolutionize the world’s health care system. 
Although dietary factors are effective modulators of cellular 
metabolism at the molecular level, it is becoming increasingly 
clear that there is considerable variability in the response of 
plasma lipids to various nutritional lipid-lowering therapies 
including plant sterols (Jones et al 1999) and dietary ﬁ  bers 
(Cara et al 1992). This variable inter-individual response is 
in part due to single base variations within gene sequences 
that function as molecular targets of dietary bioactive com-
ponents (Trujillo et al 2006). Although the inﬂ  uence of 
genetic polymorphisms on the lipoprotein proﬁ  le in response 
to plant sterols (Plat and Mensink 2002), dietary cholesterol 
(Robitaille et al 2007), and soy isoﬂ  avones (Hall et al 2006) 
have been extensively studied, the role of genotype in deter-
mining the hypocholesterolemic effects of dietary ﬁ  bers has 
been the subject of few investigations.
Apolipoprotein E (ApoE), the major apoprotein 
component of chylomicrons, is polymorphic and thought to 
inﬂ  uence the response of plasma lipids to dietary intervention Vascular Health and Risk Management 2008:4(5) 1028
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strategies (Zannis 1986). Jenkins’ group has addressed the 
association between gene polymorphisms and the lipid-
lowering response to dietary ﬁ  ber consumption in three 
separate publications. In the ﬁ  rst of these publications, 
Jenkins and colleagues (1993) examined the association 
between the three common apo E alleles (E2, E3, and E4) and 
the plasma cholesterol response observed in 67 volunteers 
who completed a controlled dietary intervention that included 
a 2 week consumption of oat bran or wheat bran at a level of 
6.8 g ﬁ  ber/1000 kcal. Total cholesterol, LDL-cholesterol, and 
apolipoprotein B (ApoB) concentrations were signiﬁ  cantly 
lower in subjects heterozygous for the E2 allele following 
ﬁ  ber consumption in comparison to the E3 homozygotes 
and E4 carriers. However, a more recent study by Wu and 
colleagues (2007),  using 22,915 free-living participants from 
the European Prospective Investigation of Cancer Norfolk 
study, suggest that ApoE genotype does not reﬂ  ect changes 
in plasma cholesterol proﬁ  le in response to dietary fat or ﬁ  ber 
intake. The authors propose that the apparent controversy 
surrounding the role of ApoE phenotypes in the serum lipid 
response to diet is likely due to the lack of statistical power 
associated with the small sample size used as part of the 
experimental design in previous investigations. In a second 
study from the Jenkins lab, Hegele and colleagues (1993) 
hypothesized that polymorphisms in genes regulating ApoB 
metabolism, including the low-density lipoprotein receptor 
(LDLr), ApoB, apolipoprotein CIII (ApoCIII), and hepatic 
lipase, could inﬂ  uence the ﬁ  ber-related reduction of ApoB 
containing lipoproteins. The results of this investigation sug-
gested that LDLr genotype had a signiﬁ  cant impact on the 
plasma lipid response following dietary ﬁ  ber consumption. 
Finally, a preliminary investigation by Hegele and colleagues 
(1997) suggested that genetic variations in the fatty acid bind-
ing protein 2 gene, involved in regulating intestinal fatty acid 
absorption and intracellular transport (Hanhoff et al 2002), 
may be involved in modulating the reductions in plasma cho-
lesterol in response to dietary ﬁ  ber consumption. However, 
the authors suggest that the results be interpreted with caution 
due to the small sample size (n = 43) and the marginality 
associated with some of the statistical outcomes.
As can be seen from the above discussion, published reports 
on the role of gene polymorphism in the cholesterol-lower-
ing response to soluble ﬁ  bers are few and often limited by 
small sample size. The hypocholesterolemic effects of dietary 
ﬁ  bers are initiated by primary intestinal events related to the 
digestion and absorption of dietary fat and cholesterol (Lairon 
1996). Therefore, investigation into the association between 
polymorphisms in genes that regulate intestinal triglyceride 
and cholesterol digestion and plasma lipoprotein outcomes in 
response to soluble ﬁ  ber consumption may be prudent. Indeed, 
pancreatic triglyceride lipase and carboxyl ester lipase, two 
enzymes involved in intestinal triglyceride and cholesterol 
digestion, have been shown to be highly polymorphic and 
may therefore explain some of the variability associated with 
dietary fiber consumption (Lidberge et al 1992; Cao and 
Hegele 2003).
The ‘omics’ approach to dietary 
ﬁ  ber research
The focus of modern day nutrition research is shifting with 
the advent of novel, high-throughput investigative tools that 
permit an examination of how nutrients affect the global 
expression and characterization of transcripts, proteins, and 
metabolites (Afman and Muller 2006). The application of 
multiplexing technology involved in nutrigenomics, nutri-
epigenetics, transcriptomics, proteomics, and metabolomics 
will advance our understanding of nutrient-gene-metabolite 
interactions and ultimately lead to the identiﬁ  cation of novel 
biomarkers of disease risk and the development of effective 
functional food products (Trujillo et al 2006). Although this 
‘omics’ approach to nutrition may currently be limited by 
its high expense and the need for highly qualiﬁ  ed individu-
als to analyze and integrate the vast amount of data that are 
generated, it has given us valuable insight into how the con-
sumption of various dietary ingredients, including dietary fat 
(Kim et al 2004), soy isoﬂ  avones (Fuchs et al 2007b), dietary 
zinc (Blanchard et al 2001), and plant sterols (Calpe-Berdiel 
et al 2007), affect global gene expression and cell metabo-
lism. However, very few published reports have applied 
‘omic’ technology to the dietary ﬁ  ber ﬁ  eld. One exception 
has been a recently published report by Fuchs and colleagues 
(2007a) who applied a proteomic approach to study the effect 
of ﬂ  axseed consumption on differentially expressed genes 
in human peripheral blood mononuclear cells. Flaxseed con-
sumption at a level of  0.4 g/kg BW for 7 days, resulted in 16 
differentially expressed proteins compared with the control 
group. This differential protein expression pattern included 
enhanced levels of peroxiredoxin and reduced expression of 
long-chain fatty acid β-oxidation multienzyme complex and 
glycoprotein IIIa/II, suggestive of an antithrombotic and anti-
inﬂ  ammatory effect from the ﬂ  axseed treatment. Microarray 
technology has also been employed to study the mechanisms 
by which intestinal SCFA produced from ﬁ  ber fermentation 
in the large intestine affect the progression of colon cancers 
(Mariadason et al 2000; Daly et al 2006). Given the hetero-
geneity associated with dietary ﬁ  bers, it is likely that ﬁ  ber Vascular Health and Risk Management 2008:4(5) 1029
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sources with different physiochemical properties will produce 
a unique metabolic ‘footprint’. Furthermore, the movement 
of nutrition research from a reductionist science to a systems 
biology approach will allow the integration of complex bio-
logical information at the gene, protein, and metabolite level 
and advance our understanding of the role of dietary soluble 
ﬁ  ber in achieving optimal personalized health.
Regulation of genes and protein 
expression within the enterohepatic loop
In order to avoid the potential atherogenic consequences 
associated with elevated plasma cholesterol, elaborate 
regulatory mechanisms have evolved to balance the intestinal 
absorption and de novo synthesis of cholesterol (the major 
input pathways) with biliary cholesterol and bile acid excre-
tion (the major output pathways) (Lammert and Wang 
2005). Our understanding of the molecular regulators of 
enterohepatic cholesterol and bile acid metabolism has been 
greatly advanced through the characterization of the major 
proteins involved in maintaining sterol balance at the intestinal 
and hepatic levels (Figure 2). Within the intestine, cholesterol 
absorption and efﬂ  ux appear to be regulated largely through 
the brush-border membrane proteins Niemann-Pick C like 
1 and ATP-binding cassette G5 and G8, respectively (Kruit 
et al 2006). At the hepatic level, the clearance of plasma 
LDL and HDL-cholesterol occurs through the LDLr and the 
scavenger receptor class B, type 1 (SR-B1) while cholesterol 
synthesis and oxidation is precisely controlled through activity 
of the rate-limiting enzymes HMG-CoAr and cholesterol 
7α-hydroxylase (CYP7A1), respectively (Dietschy et al 
1993). Furthermore, the inﬂ  uence of hepatic ABCG5/G8 
expression on biliary cholesterol secretion and intestinal 
cholesterol absorption has only recently been recognized 
(Wu et al 2004; Rideout and Fan 2008). Finally, numerous 
nuclear receptors (eg, LXR, FXR) and transcription factors 
(eg, SREBP2) have been shown to be critical in modulating 
transcriptional events and maintaining cholesterol homeostasis 
within the enterohepatic loop (Wong et al 2006).
Figure 2 Major pathways involved in regulating the enterohepatic circulation of cholesterol. Copyright © 2007.   Adapted with permission from Rideout TC,   Yuan Z, Bakovic M, 
et al. 2007. Guar gum consumption increases hepatic nuclear SREBP2 and LDL receptor expression in pigs fed an atherogenic diet.  J Nutr, 137:568–72.
Abbreviations: ABCG5, ATP-binding cassette transporter G5; ABCG8, ATP-binding cassette transporter G5; ACAT, acyl-coenzyme A:cholesterol acyltransferase; ASBT, apical 
sodium-dependent bile acid transporter; C, cholesterol; CE, cholesteryl ester; CEL, carboxyl ester lipase; CYP7A, cholesterol 7α-hydroxylase; HDL, high-density lipoprotein; 
ABCA1, ATP-binding cassette transporter A1; HMG-CoAr, 3-hydroxy-3-methylglutaryl-CoA reductase; LDLr, low-density lipoprotein receptor; NPC1L1, Niemann-Pick-C-1 
like 1; SR-B1, scavenger receptor class B, type 1; VLDL, very-low density lipoprotein.
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Information concerning the effect of dietary fiber 
consumption on the expression of genes that regulate 
intestinal cholesterol absorption and hepatic sterol balance is 
limited. For the most part, published reports on the molecular 
mechanisms associated with the hypocholesterolemic 
effects of dietary ﬁ  bers have pertained to the hepatic mRNA 
expression of  HMG-CoAr and CYP7A1 (Horton et al 1994; 
Kishida et al 2002; Han et al 2004). Although these studies 
have provided insight into how ﬁ  bers may affect metabolism 
at the gene level, the expression of a gene from DNA to 
protein is a complex process with control mechanisms that 
regulate multiple steps including transcription rate, nuclear 
export and mRNA localization, transcript stability, transla-
tional efﬁ  ciency, protein degradation, and post-translational 
processing (Pradet-Balade et al 2001; Hanash and Beretta 
2002; Yang et al 2008). Therefore, cellular mRNA levels 
are often unreliable indicators of protein abundances, and 
the abundance of any particular protein does not necessarily 
reflect its catalytic activity (Hanash and Beretta 2002). 
In an effort to more fully characterize the hypocholester-
olemic effects of soluble ﬁ  ber at the molecular level, our 
recent work proposes several novel mechanisms by which 
GG may exert its effects. Firstly, our data suggests that the 
hypocholesterolemic effects of GG consumption are mediated 
by a reduction in hepatic free-cholesterol concentration and 
an associated SREBP2-dependent increase in hepatic LDLr 
mRNA and protein expression (Rideout et al 2007). At 
the transcriptional level, hepatic cholesterol metabolism is 
tightly controlled through SREBP2, a nuclear receptor that 
binds to sterol response elements in the promoter region of a 
multitude of target genes (Hua et al 1993). In the absence of 
a change in SREBP2 mRNA, we observed an increase in the 
cytoplasmic precursor and nuclear active forms of SREBP2 
without a corresponding increase in the cytoplasmic mature 
form of the protein in response to GG consumption. This 
differential expression pattern suggests GG consumption 
may have increased nuclear SREBP2 expression through 
mechanisms independent of protease-dependent cleavage 
at the Golgi.
Secondly, in response to GG consumption we observed 
an increase in hepatic ABCG5/G8 mRNA and protein 
expression and biliary cholesterol concentration in compari-
son to the control-fed pigs (Rideout 2007; Rideout and Fan 
2008). Traditionally, by interfering with the enterohepatic 
circulation and intestinal uptake of  bile acids, soluble ﬁ  ber 
consumption is believed to modulate whole-body cholesterol 
excretion through stimulation of cholesterol catabolism to 
bile acids (Trautwein et al 1998). However, an additional 
quantitatively important route of cholesterol excretion occurs 
through the biliary secretion and eventual fecal loss of free 
cholesterol (Spritz et al 1965). Our recent data suggest that 
the stimulation of biliary free cholesterol secretion through 
hepatic ABCG5/G8 may exist as a novel mechanism by 
which GG consumption stimulates whole-body cholesterol 
loss and effectively reduces plasma cholesterol concentrations 
(Rideout 2007; Rideout and Fan 2008).
Both targeted traditional molecular approaches and 
novel high-throughput technology may be employed to 
gain a more comprehensive understanding of how dietary 
soluble ﬁ  ber consumption regulates gene and protein express 
patterns. Unlike other dietary bioactive components that 
are thought to directly regulate the transcription of hepatic 
cholesterol-responsive genes (Mezei et al 2003), dietary 
ﬁ  ber components are not absorbed from the gastrointestinal 
tract and therefore are generally thought to inﬂ  uence hepatic 
cholesterol homeostasis through secondary signaling 
systems and metabolites (Fernandez 1995). Therefore, to 
fully delineate the molecular events by which soluble ﬁ  ber 
consumption modulates peripheral cholesterol metabolism, 
it will be critical to determine the molecular signals that are 
involved in mediating these secondary effects.
Conclusions
Although dietary ﬁ  ber may be considered a ‘dinosaur’ among 
other functional foods, it should not be perceived as extinct. The 
future relevance of functional ﬁ  ber-based foods will depend 
on the ability to integrate consumer health concerns with a 
comprehensive understanding of the health beneﬁ  ts and disease-
prevention potential of unique varieties of soluble ﬁ  bers. Due to 
the speciﬁ  c physical-chemical attributes that are associated with 
ﬁ  bers that originate from different plant sources and produced 
with alternative processing technologies, dietary ﬁ  bers are 
unique functional ingredients that have wide-ranging appeal in 
the functional food community. While the hypocholesterolemic 
effects associated with soluble ﬁ  ber consumption are clear, a 
comprehensive understanding of these effects, particularly at the 
molecular level, will require additional exploration. Advances 
in understanding the variable interindividual response to dietary 
soluble ﬁ  bers and the effect of ﬁ  ber consumption on expression 
patterns at the gene, protein and metabolite level will advance 
through application of traditional molecular tools and novel high-
throughput technology. Detailed knowledge of the mechanisms 
by which different soluble ﬁ  bers reduce plasma cholesterol 
concentrations is paramount to developing novel ﬁ  ber-based 
“cocktails” and portfolio-type diets that target speciﬁ  c metabolic 
pathways to gain maximal cholesterol reductions.Vascular Health and Risk Management 2008:4(5) 1031
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